Paper41806331
NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process.
Wang H and 9 others. FASEB J, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process. Papers, record 41806331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41806331
- Cell line
- HEK293T2,726 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Notch3 | Major topic |
| CADASIL | Major topic |
| Humans | |
| Mutation | |
| Signal Transduction | |
| Animals | |
| HEK293 Cells |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KWF Kankerbestrijding (KWF) | PubMed | |||
| Oncode Institute | PubMed |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29196606 | Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1). | J Biol Chem | 2018 | https://conductscience.org/library/papers/29196606 | PubMed |
| 2 | 69080 | Chronic familial vascular encephalopathy. | Lancet | 1977 | https://conductscience.org/library/papers/69080 | PubMed |
| 3 | 29757481 | Severe white matter astrocytopathy in CADASIL. | Brain Pathol | 2018 | https://conductscience.org/library/papers/29757481 | PubMed |
| 4 | 22239429 | Pericytes as a new target for pathological processes in CADASIL. | Neuropathology | 2012 | https://conductscience.org/library/papers/22239429 | PubMed |
| 5 | 40265482 | Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort - Implications for NOTCH3 Variant-Specific Disease Prediction. | Ann Neurol | 2025 | https://conductscience.org/library/papers/40265482 | PubMed |
| 6 | 25700513 | Structural biology. Structural basis for Notch1 engagement of Delta-like 4. | Science | 2015 | https://conductscience.org/library/papers/25700513 | PubMed |
| 7 | 27821617 | Increased Notch3 Activity Mediates Pathological Changes in Structure of Cerebral Arteries. | Hypertension | 2017 | https://conductscience.org/library/papers/27821617 | PubMed |
| 8 | 29514050 | Mechanism of aggregation and membrane interactions of mammalian prion protein. | Biochim Biophys Acta Biomembr | 2018 | https://conductscience.org/library/papers/29514050 | PubMed |
| 9 | 12015144 | The structure of the mammalian 20S proteasome at 2.75 A resolution. | Structure | 2002 | https://conductscience.org/library/papers/12015144 | PubMed |
| 10 | 39864627 | Light-chain split luciferase assay implicates pathological NOTCH3 thiol reactivity in inherited cerebral small vessel disease. | J Biol Chem | 2025 | https://conductscience.org/library/papers/39864627 | PubMed |
| 11 | 36606642 | Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. | J Clin Neurol | 2023 | https://conductscience.org/library/papers/36606642 | PubMed |
| 12 | 20071773 | Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20071773 | PubMed |
| 13 | 35332121 | Notch signaling pathway: architecture, disease, and therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35332121 | PubMed |
| 14 | 35393494 | Oligomerization, trans-reduction, and instability of mutant NOTCH3 in inherited vascular dementia. | Commun Biol | 2022 | https://conductscience.org/library/papers/35393494 | PubMed |
| 15 | 32231578 | Pathophysiological Mechanisms and Potential Therapeutic Targets in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL). | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32231578 | PubMed |
| 16 | 38254727 | Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease. | Biomolecules | 2024 | https://conductscience.org/library/papers/38254727 | PubMed |
| 17 | 41174998 | Dimerization-dependent NOTCH receptor transactivation unveils a class of highly selective NOTCH signalling inhibitors. | FEBS J | 2026 | https://conductscience.org/library/papers/41174998 | PubMed |
| 18 | 28716282 | Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL. | J Neurol Sci | 2017 | https://conductscience.org/library/papers/28716282 | PubMed |
| 19 | 21628316 | Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21628316 | PubMed |
| 20 | 27423596 | Phenotypic comparison of individuals with homozygous or heterozygous mutation of NOTCH3 in a large CADASIL family. | J Neurol Sci | 2016 | https://conductscience.org/library/papers/27423596 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42684564 | Potential contributors to variable penetrance of NOTCH3 p.Arg1231Cys Variant. | Neurogenetics | 2026 | https://conductscience.org/library/papers/42684564 |
Source PubMed
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41806331
GET https://conductscience.org/api/papers/v1/41806331/references?page=2